|
US5830702A
(en)
|
1990-10-31 |
1998-11-03 |
The Trustees Of The University Of Pennsylvania |
Live, recombinant listeria monocytogenes and production of cytotoxic T-cell response
|
|
US8791237B2
(en)
|
1994-11-08 |
2014-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of non-hodgkins lymphoma
|
|
US6051237A
(en)
|
1994-11-08 |
2000-04-18 |
The Trustees Of The University Of Pennsylvania |
Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector
|
|
US8114414B2
(en)
|
1994-11-08 |
2012-02-14 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical cancer
|
|
US20070264279A1
(en)
*
|
1994-11-08 |
2007-11-15 |
Claudia Gravekamp |
Compositions and methods comprising a MAGE-b antigen
|
|
US7820180B2
(en)
|
2004-09-24 |
2010-10-26 |
The Trustees Of The University Of Pennsylvania |
Listeria-based and LLO-based vaccines
|
|
US7794729B2
(en)
*
|
1994-11-08 |
2010-09-14 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for immunotherapy of cancer
|
|
US7662396B2
(en)
|
2001-03-26 |
2010-02-16 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing the immunogenicity of antigens
|
|
US8956621B2
(en)
|
1994-11-08 |
2015-02-17 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical dysplasia
|
|
US6099848A
(en)
|
1997-11-18 |
2000-08-08 |
The Trustees Of The University Of Pennsylvania |
Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use
|
|
US9012141B2
(en)
|
2000-03-27 |
2015-04-21 |
Advaxis, Inc. |
Compositions and methods comprising KLK3 of FOLH1 antigen
|
|
JP2004500405A
(ja)
|
2000-03-29 |
2004-01-08 |
ザ トラスティーズ オブ ザ ユニバーシティー オブ ペンシルヴァニア |
抗原の免疫原性を増強するための組成物および方法
|
|
US6855320B2
(en)
|
2000-03-29 |
2005-02-15 |
The Trustees Of The University Of Pennsylvania |
Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity
|
|
US8771702B2
(en)
|
2001-03-26 |
2014-07-08 |
The Trustees Of The University Of Pennsylvania |
Non-hemolytic LLO fusion proteins and methods of utilizing same
|
|
US7700344B2
(en)
|
2001-03-26 |
2010-04-20 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing the immunogenicity of antigens
|
|
JP2005527240A
(ja)
|
2002-05-29 |
2005-09-15 |
ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
弱毒リステリア種とこれを使用する方法
|
|
CA2512812A1
(en)
|
2003-01-09 |
2004-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
|
|
US7855064B2
(en)
|
2004-08-13 |
2010-12-21 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free vaccines and methods for constructing and using same
|
|
ES2684749T3
(es)
|
2004-08-13 |
2018-10-04 |
The Trustees Of The University Of Pennsylvania |
Métodos para construir vacunas sin resistencia a antibióticos
|
|
US7858097B2
(en)
*
|
2004-08-13 |
2010-12-28 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free Listeria strains and methods for constructing and using same
|
|
AU2005295158A1
(en)
*
|
2004-10-18 |
2006-04-27 |
Medimmune, Llc |
High cell density process for growth of Listeria
|
|
US7935804B2
(en)
|
2006-03-01 |
2011-05-03 |
Aduro Biotech |
Engineered Listeria and methods of use thereof
|
|
US8268326B2
(en)
|
2006-08-15 |
2012-09-18 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
|
|
PT2977456T
(pt)
|
2006-08-15 |
2018-02-05 |
Univ Pennsylvania |
Composições compreendendo hmw-maa e seus fragmentos para tratamento do cancro
|
|
WO2008130551A2
(en)
|
2007-04-16 |
2008-10-30 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free listeria strains and methods for constructing and using same
|
|
CN102076843A
(zh)
*
|
2008-05-19 |
2011-05-25 |
艾杜罗生物科技公司 |
包含prfa*突变体李斯特菌的组合物及其使用方法
|
|
US9017660B2
(en)
|
2009-11-11 |
2015-04-28 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
|
|
US20120135033A1
(en)
|
2008-05-19 |
2012-05-31 |
Anu Wallecha |
Multiple delivery system for heterologous antigens
|
|
US20140234370A1
(en)
|
2009-11-11 |
2014-08-21 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
|
US9650639B2
(en)
|
2008-05-19 |
2017-05-16 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens
|
|
US20150366955A9
(en)
|
2009-11-11 |
2015-12-24 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
|
ES2741730T3
(es)
|
2008-05-19 |
2020-02-12 |
Advaxis Inc |
Sistema de administración doble para antígenos heterólogos que comprende una cepa de Listeria recombinante atenuada por la mutación de dal/dat y la deleción de ActA que comprende una molécula de ácido nucleico que codifica una proteína de fusión de listeriolisina O - antígeno prostático específico
|
|
US20120100170A1
(en)
*
|
2008-07-24 |
2012-04-26 |
Lauer Peter M |
Compositions and methods for the treatment of hepatitis c
|
|
JP5539411B2
(ja)
|
2009-03-04 |
2014-07-02 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
血管新生因子を含む組成物およびその使用方法
|
|
US10016617B2
(en)
|
2009-11-11 |
2018-07-10 |
The Trustees Of The University Of Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
|
|
EP2498808A4
(en)
|
2009-11-11 |
2014-01-08 |
Advaxis |
COMPOSITIONS AND METHOD FOR PREVENTING FLUID MUTATIONS IN THE TREATMENT OF TUMORS WITH HER2 / NEW OVEREXPRESSION
|
|
US20110223187A1
(en)
|
2010-02-15 |
2011-09-15 |
Vafa Shahabi |
Live listeria-based vaccines for central nervous system therapy
|
|
US20110305724A1
(en)
|
2010-04-19 |
2011-12-15 |
Yvonne Paterson |
Immunotherapeutic, anti-tumorigenic compositions and methods of use thereof
|
|
WO2012138377A2
(en)
|
2010-10-01 |
2012-10-11 |
Trustees Of The University Of Pennsylvania |
The use of listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
|
|
ES2684684T3
(es)
*
|
2010-11-17 |
2018-10-04 |
Aduro Biotech, Inc. |
Métodos y composiciones para inducir una respuesta inmune al EGFRVIII
|
|
WO2012125551A1
(en)
*
|
2011-03-11 |
2012-09-20 |
Advaxis |
Listeria-based adjuvants
|
|
EP2825195A4
(en)
|
2012-03-12 |
2015-10-07 |
Advaxis Inc |
INHIBITION OF SUPPRESSOR CELL FUNCTION AFTER TREATMENT WITH A LISTERIAL VACCINE
|
|
MX2016010791A
(es)
|
2014-02-18 |
2017-04-27 |
Advaxis Inc |
Inmunoterapia con multiples objetivos dirigida por biomarcadores.
|
|
CN106661538A
(zh)
|
2014-02-25 |
2017-05-10 |
阿德瓦希斯公司 |
用于治疗her2/neu过表达肿瘤的组合物和方法
|
|
MA39717A
(fr)
|
2014-03-05 |
2017-01-11 |
Advaxis Inc |
Procédés et compositions pour accroître le rapport des lymphocytes t effecteurs aux lymphocytes t régulateurs
|
|
MA39849A
(fr)
|
2014-04-24 |
2017-03-01 |
Advaxis Inc |
Souches de listeria utilisées comme vaccin recombinant et procédé de production
|
|
SG11201609135VA
(en)
|
2014-05-02 |
2016-11-29 |
Univ Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of her-2-positive cancers
|
|
SG11201700092XA
(en)
|
2014-07-18 |
2017-02-27 |
Advaxis Inc |
Recombinant listeria strain expressing heterologous antigen fusion proteins and methods of use thereof
|
|
JP2017522322A
(ja)
|
2014-07-18 |
2017-08-10 |
アドバクシス， インコーポレイテッド |
抗腫瘍応答を引き出すためのリステリアベースの免疫原性組成物
|
|
MX2017000857A
(es)
|
2014-07-18 |
2017-10-11 |
Advaxis Inc |
Combinación de un antagonista de la proteina de muerte programada (pd-1) y una vacuna basada en listeria para tratar el cáncer de próstata.
|
|
WO2016011320A1
(en)
|
2014-07-18 |
2016-01-21 |
Advaxis, Inc. |
Bivalent listeria-based delivery system of heterologous antigens
|
|
US20160228530A1
(en)
|
2014-10-14 |
2016-08-11 |
The Trustees Of The University Of Pennsylvania |
Combination therapy for use in cancer therapy
|
|
MA41217A
(fr)
|
2014-12-19 |
2017-10-24 |
Advaxis Inc |
Polythérapies ayant des souches de listeria recombinées
|
|
WO2016126878A2
(en)
|
2015-02-03 |
2016-08-11 |
The Trustees Of The University Of Pennsylvania |
Listeria-based immunomodulation
|
|
WO2016126876A2
(en)
|
2015-02-03 |
2016-08-11 |
Advaxis, Inc. |
Listeria-based adjuvants
|
|
US20160220652A1
(en)
|
2015-02-03 |
2016-08-04 |
Advaxis, Inc. |
Methods of using recombinant listeria vaccine strains in disease immunotherapy
|
|
MA41644A
(fr)
|
2015-03-03 |
2018-01-09 |
Advaxis Inc |
Compositions à base de listeria comprenant un système d'expression de minigènes codant pour des peptides, et leurs procédés d'utilisation
|
|
WO2016154412A2
(en)
|
2015-03-26 |
2016-09-29 |
The Trustees Of The University Of Pennsylvania |
Combination of a pd-1 antagonist and a listeria based vaccine for treating pancreatic cancer
|
|
US20180104284A1
(en)
|
2015-05-13 |
2018-04-19 |
Advaxis, Inc. |
Immunogenic Listeria-Based Compositions Comprising Truncated Acta-Antigen Fusions And Methods Of Use Thereof
|
|
CA2987239A1
(en)
|
2015-05-26 |
2016-12-01 |
Advaxis, Inc. |
Personalized delivery vector-based immunotherapy and uses thereof
|
|
EP3313975A4
(en)
|
2015-06-24 |
2019-03-13 |
Advaxis, Inc. |
MANUFACTURING DEVICE AND METHOD FOR PERSONALIZED ADMINISTRATION OF VECTOR-BASED IMMUNOTHERAPY
|
|
US20180305702A1
(en)
|
2015-09-15 |
2018-10-25 |
Advaxis, Inc. |
Listeria-Based Immunogenic Compositions And Methods Of Use Thereof in Cancer Prevention And Treatment
|
|
HK1258860A1
(zh)
|
2015-09-15 |
2019-11-22 |
Advaxis, Inc. |
含有重组李斯特氏菌株的免疫治疗制剂的制作方法
|
|
EP3349789A2
(en)
|
2015-09-17 |
2018-07-25 |
Advaxis, Inc. |
Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy
|
|
JP2018530588A
(ja)
|
2015-10-14 |
2018-10-18 |
アドバクシス， インコーポレイテッド |
組み換え型リステリアワクチン株およびガン免疫療法におけるその使用方法
|
|
US20180325964A1
(en)
|
2015-11-20 |
2018-11-15 |
Advaxis, Inc. |
Manufacturing device and method of an immunotherapeutic formulation comprising a recombinant listeria strain
|
|
WO2017106754A2
(en)
|
2015-12-16 |
2017-06-22 |
Advaxis, Inc. |
Listeria-based immunotherapy and methods of use thereof
|
|
US20190032064A1
(en)
|
2016-01-27 |
2019-01-31 |
Advaxis, Inc. |
Personalized Delivery Vector-Based Immunotherapy and Uses Thereof
|
|
CA3029235A1
(en)
|
2016-07-05 |
2018-01-11 |
Advaxis, Inc. |
Listeria-based immunogenic compositions comprising wilms tumor protein antigens and methods of use thereof
|
|
WO2018085854A1
(en)
|
2016-11-07 |
2018-05-11 |
Advaxis, Inc. |
Combination of listeria-based vaccine with anti-ctla-4 or anti-cd137 antibodies
|
|
MX2019005685A
(es)
|
2016-11-30 |
2019-09-04 |
Advaxis Inc |
Composiciones inmunogenicas contra mutaciones de cancer recurrentes y metodos de uso de las mismas.
|
|
WO2018102585A1
(en)
|
2016-11-30 |
2018-06-07 |
Advaxis, Inc. |
Personalized immunotherapy in combination with immunotherapy targeting recurrent cancer mutations
|
|
WO2018129306A1
(en)
|
2017-01-05 |
2018-07-12 |
Advaxis, Inc. |
Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy
|